of delivery, with gestational age between 25 and 42 wk. In influencing chemotaxis (12-14) and phagocytosis (15. 16). and mothers, an inverse linear relationship between gestational altering surface membrane receptor expression (17) (18) (19) (20) .
age and GM-CSF levels ( p = 0.049) was found, but no
The clinical use of G-CSF and GM-CSF has included the association with G-CSF levels was observed. In neonates, acceleration of neutrophil recovery after chemotherapy and bone a quadratic association was found between GM-CSF levels maITOW transplantation, the treatment of ne~tropenia associated and gestational age ( p = 0.019), whereas G-CSF levels with infections, myelodysplasia or irradiation exposure, and conshowed an inverse linear association ( p = 0.015). In addi-genital neutropenia (21) (22) (23) (24) (25) (26) . Their use in the management of tion, an association was found between maternal and cord infection has not been evaluated. Animal studies have suggested GM-CSF ( p = 0.007) but not G-CSF levels in paired that an improved outcome in neonatal sepsis may be achieved samples. ~h~ effect of gestational age on the cytokine using a combination of G-CSF or GM-CSF with antibiotics (27-levels could not be explained by the white cell count, the 29). Roberts @t ul. (30) have reported the use of G-CSF in an absolute neutrophil count, pregnancy-induce,j hyperten-infected human neonate with neutropenia without adverse effect. sion, or the presence of infection. we suggest that 1 ) G M -resulting in an improvement in neutrophil count and elimination CSF levels in mothers vary throughout gestation and may sepsis. have a role in the maintenance of normal pregnancy; 2 ) GDespite this increasing clinical use, little is known about the CSF and GM-CSF levels in neonates vary with gestational endogenous levels and significance of circulating G-CSF and age and may have a developmental role; and 3) G -C S~ has GM-CSF. Serum GM-CSF levels are undetectable in normal theoretical benefit in the management of neonatal neutro-healthy adults (9. 31). and raised levels have not been documented vet. In contrast, raised serum G-CSF levels have been penia and sepsis; clinical trials are now needed to establish found in+ of normal adults (32) , in the presence of infection its optimal use. (Pediatr Res 35: 164-168. 1994) (33. 34) . and some cases of congenital neutropenia (35) . In fullterm healthy neonates, Laver et ul. (36) measured G-CSF and Abbreviations GM-CSF using a bioassay and demonstrated raised levels of both cytokines when compared with normal adults. However, Cairo CSF, colony-stimulating factor rt ul. (37. 38) were unable to detect G-CSF or GM-CSF in a G-CSF, granulocyte colony-stimulating factor similar group using an immunoassay. Data concerning serum GM-CSF, granuloc~te-macro~hage colon~-stimulating G-CSF and GM-CSF levels in premature neonates have not been factor reported. PIH, pregnancy-induced hypertension
The aim of this study was to examine the endogenous levels WCC, white cell count of G-CSF and GM-CSF in cord blood at various stages of ANC, absolute neutrophil count gestation and to examine the influence of maternal CSF levels. infection. and the reasons for premature delivery on the values obtained. Ethical approval for the study was obtained from The Research Ethical Committee of the Faculty of Medicine of The Queen's University of Belfast.
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neonates were all singletons and ranged in gestational age from 25 to 42 wk at the time of delivery. Premature delivery was precipitated by the following maternal antenatal complications: PIH, diabetes mellitus, bleeding, or premature rupture of membranes (at <36 completed wk), or fetal distress. Thirty-three neonates were delivered vaginally, and 48 were delivered by cesarean section, of which 36 were elective procedures.
The incidence of infection in both mothers and babies was obtained from case note review. Maternal infection was diagnosed when pyrexia of 38°C or more occurred or when cultures of urine, sputum, or vaginal swab were found to be positive. Only episodes occumng 48 h before or 48 h after delivery were considered to have a potential influence on cytokine levels at the time of delivery. Neonatal infection was diagnosed by clinical assessment, with or without positive cultures of blood, urine, gastric aspirate, or bronchial secretions. Only early infection (39) . occumng within the first 48 h of delivery, was considered to have a potential influence on cytokine levels at birth. The perinatal details of the study cases are summarized in Table I .
Serum samples. After patients provided informed consent, blood samples were obtained from the mother and the umbilical cord at the time of delivery. The clotted samples were immediately separated, and the sera were stored in aliquots at -20°C until analysis. This form of storage has previously been shown not to alter immunoassay results (40) . At the same venipuncture. a sample was drawn to record the WCC and differential WCC.
ELISA. Commercially available assay kits for the measurement of G-CSF (Amgen Biologicals, Thousand Oaks. CA, sensitivity 5 ng/L) and GM-CSF (Medical Resources Ltd., Sydney. Australia, sensitivity 0.5 ng/L) were used. Both assays are based on the double-antibody sandwich method. Antibody precoated plates were incubated with standards or serum samples in duplicate. Rabbit anti-CSF, horseradish peroxidase-conjugated antirabbit antibody, and horseradish peroxidase substrate were added sequentially, with a washing step before each addition to remove uncaptured components. The final horseradish peroxidase substrate reaction was terminated by the addition of a weak acid solution before reading the absorbance on an ELISA plate reader (Dynatech MR 700, Dynatech, Cambridge, MA). No crossreactivity with other cytokines or other serum components has been reported (manufacturer's data). A standard curve constructed with the means of the duplicate results was used to determine the values for CSF in the test sera.
Statistical analysis. Mother-baby pairs were divided into five groups by gestational age. Because of the occurrence of values below the sensitivity of the assays, mean and SD could not be calculated for each group. Hence the actual values obtained in the ELISA were catagorized into "raised" and "not raised" groups, with reference to the expected normal adult value. The normal adult values were less than 30 ng/L for GM-CSF (9) and less than 50 ng/L for G-CSF (8) . The values for WCC and ANC were transformed using natural logarithms before analysis. The continuous variables, namely. gestation. WCC. and ANC. were evaluated for association with CSF levels using independent samples t tests. The analysis of WCC and ANC were then adjusted for the confounding effects of gestation using logistic regression analysis. The variables PIH and infection were classified as either present or absent and were initially evaluated for association with CSF levels using the x' test. These associations were then reexamined in five strata defined by gestational age. using the Mantel-Haenstal stratified x' test to adjust for the confounding effects of gestation.
RESULTS
The ranges of results obtained by ELISA for each gestational age group are shown in Figures 1 through 4 . Cases in which the levels of cytokine were below the sensitivity of the assay were, for illustrative purposes only, assigned a value of 5 ng/L (GM-CSF) and 20 ng/L (G-CSF). Tables 2 and 3 give a summary of the statistical analysis.
GM-CSF values were obtained in 56 maternal sera, of which 18 had raised values ranging from 48 to 190 ng/L (Fig. 1 ). An inverse linear association between GM-CSF level and stage of gestation was found ( p = 0.049).
GM-CSF values were obtained in 58 cord sera, of which 14 had raised values ranging from 32 to 200 ng/L (Fig. 2) . A quadratic association between gestational age and cord GM-CSF level was demonstrated ( p = 0.019), with the greatest frequency of raised values occumng between 28 and 36 wk. In addition. an association between GM-CSF levels in maternal and cord sera was noted ( p = 0.007).
G-CSF values were obtained in 46 maternal sera, of which six were found to have raised levels ranging from 250 to I000 ng/L (Fig. 3) . These levels occurred between 28 and 36 wk, but no association with gestational age could be demonstrated.
G-CSF values were obtained in 64 cord sera, of which 15 were found to have raised values ranging from 75 to 3750 ng/L (Fig.  4 ). An inverse linear association between G-CSF level and gestational age was shown ( p = 0.015). No correlation was seen between maternal and cord G-CSF levels.
G-CSF or GM-CSF levels in cord or maternal sera were not 
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MOTHERS associated with the WCC or ANC or with the presence of infection or PIH. In addition, the observed effect of gestation could not be accounted for by any of these variables (Tables 2  and 3 ).
DISCUSSION
The role of G-CSF and GM-CSF in the control of hematopoiesis and their effects on mature cell function have been well established (2 1-26). Measurement of circulating CSF in adults has indicated that under normal conditions both G-CSF and GM-CSF are either undetectable or present in very small amounts (3 1, 32) . The levels during pregnancy have not been previously described.
Our data suggest that although maternal G-CSF levels do not vary throughout gestation, a small but significant change occurs in maternal GM-CSF levels. GM-CSF is detectable in increased amounts from at least 25 wk, but normal nonpregnant adult levels are apparent at full term. The role of GM-CSF during human pregnancy remains obscure. but previous animal studies have demonstrated its production in uterine luminal or epithelial cells during early and midpregnancy (41, 42) . The association between GM-CSF levels in 56 pairs of maternal and cord samples would be in keeping with a placental source of GM-CSF and alludes to a role in the growth and development of the fetoplacental unit. The lack of association in the corresponding G-CSF levels suggests an alternative influence, although placental production of G-CSF has also been demonstrated (43) . The presence of receptors for G-CSF and GM-CSF on placental tissue (44. 45) would further support a role for these cytokines in normal pregnancy.
Raised serum levels of G-CSF have been demonstrated in acute infections (33. 34) . The lack of association between infection, documented in 20% of mothers in the study, and G-CSF levels may reflect an altered response to infection during pregnancy.
In neonates, difficulty in the accurate assessment of sepsis, particularly in the premature infant (46) , may have led to the underrepresentation of "infection" in this group and masked an association with a raised CSF. However, in our group of premature neonates, five (6%) had documented early infection, a figure in keeping with the suggested rate of infection in premature infants (4) . Furthermore, 31 % of neonates had raised levels of G-CSF, and 32% had raised levels of GM-CSF, suggesting that infection probably does not account for all of the patients with raised CSF levels.
Neonatal G-CSF and GM-CSF levels were not associated with the presence of PIH or with the WCC or ANC, suggesting that variation in endogenous levels of G-CSF and GM-CSF with progression of gestation is independent of these variables. Our findings are in keeping with those of Cairo et al. (37, 38) , who were unable to demonstrate G-CSF or GM-CSF in cord sera of full-term neonates using an ELISA, but our results are at variance with those of Laver et al. (36) , who found high levels of both G-CSF and GM-CSF in full-term cord sera using a bioassay. This discrepancy may be accounted for by the different assay techniques used. A bioassay may be influenced by other stimulatory or inhibitory factors in test sera (3 I), whereas ELISA is specific for a single factor (3 1. 47). although it provides no functional information. We would then suggest that raised G-CSF and GM-CSF levels found in cord blood from premature neonates may have a role in fetal growth and development.
These observations are also of interest when considering the Table 3 . Cord blood: linear associations potential use of exogenous G-CSF or GM-CSF in the management of neonatal sepsis. Experience with the use of these factors in children and adults has indicated that G-CSF is well tolerated, is associated with few side effects, and can produce an improvement in neutrophil counts and a reduction in the number and severity of infections (8, (48) (49) (50) (51) (52) . In contrast. GM-CSF has been associated with more severe side effects, particularly at higher dosage, and although neutrophil numbers were improved, the number of infective episodes was not significantly altered (22. 26) . This difference in efficacy may relate to the respective effects of G-CSF and GM-CSF on neutrophil function. GM-CSF inhibits chemotaxis at high dosage ( 12, 13) and up-regulates neutrophil adhesion molecules (17) (18) (19) , leading to sequestration of neutrophils in the circulation (53) and promotion of localized vascular damage (54) . GM-CSF also promotes the release of secondary mediators such as tumor necrosis factor and IL-1 (55 
